# Nasdaq:PMVP news releases

Nasdaq:PMVP press releases distributed through HARO Newswire to the journalists who cover the beat.

- **Releases in the last 90 days:** 584
- **Web page:** https://www.helpareporter.com/news-releases/nasdaqpmvp
- **RSS:** https://www.helpareporter.com/news-releases/nasdaqpmvp/rss.xml

### [PMV Pharmaceuticals Announces Promising Updated Data From the PYNNACLE Phase 2 Pivotal Trial of Rezatapopt Monotherapy in Patients With TP53 Y220C-Mutated Advanced Solid Tumors](https://www.helpareporter.com/news-releases/pmv-pharmaceuticals-announces-promising-updated-data-from-the-pynnacle-2)

November 20, 2026 · PMV Pharma · Nasdaq:PMVP

48% confirmed overall response rate (ORR) with a 10.4-month median duration of response in the primary analysis population of 65 patients with platinum-resistant/refractory ovarian cancer 36% ORR with an 8.1-month median duration of response across all cohorts in the overall…
